Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 20 (10), 963-70

Diagnosis and Management for Urosepsis

Affiliations
Review

Diagnosis and Management for Urosepsis

Florian M E Wagenlehner et al. Int J Urol.

Abstract

Urosepsis is defined as sepsis caused by a urogenital tract infection. Urosepsis in adults comprises approximately 25% of all sepsis cases, and is in most cases due to complicated urinary tract infections. The urinary tract is the infection site of severe sepsis or septic shock in approximately 10-30% of cases. Severe sepsis and septic shock is a critical situation, with a reported mortality rate nowadays still ranging from 30% to 40%. Urosepsis is mainly a result of obstructed uropathy of the upper urinary tract, with ureterolithiasis being the most common cause. The complex pathogenesis of sepsis is initiated when pathogen or damage-associated molecular patterns recognized by pattern recognition receptors of the host innate immune system generate pro-inflammatory cytokines. A transition from the innate to the adaptive immune system follows until a T(H2) anti-inflammatory response takes over, leading to immunosuppression. Treatment of urosepsis comprises four major aspects: (i) early diagnosis; (ii) early goal-directed therapy including optimal pharmacodynamic exposure to antimicrobials both in the plasma and in the urinary tract; (iii) identification and control of the complicating factor in the urinary tract; and (iv) specific sepsis therapy. Early adequate tissue oxygenation, adequate initial antibiotic therapy, and rapid identification and control of the septic focus in the urinary tract are critical steps in the successful management of a patient with urosepsis, which includes early imaging, and an optimal interdisciplinary approach encompassing emergency unit, urological and intensive-care medicine specialists.

Keywords: sepsis therapy; systemic inflammatory response syndrome; urinary tract infections; urosepsis.

Similar articles

  • Optimal Management of Urosepsis From the Urological Perspective
    FM Wagenlehner et al. Int J Antimicrob Agents 30 (5), 390-7. PMID 17728107. - Review
    Urosepsis in adults comprises approximately 25% of all sepsis cases and in most cases is due to complicated urinary tract infections (UTIs). In this paper we review the o …
  • Therapeutic Challenges of Urosepsis
    FM Wagenlehner et al. Eur J Clin Invest 38 Suppl 2, 45-9. PMID 18826481. - Review
    Urosepsis accounts for approximately 25% of all sepsis cases and may develop from a community or nosocomial acquired urinary tract infection (UTI). The underlying UTI is …
  • An Update on Classification and Management of Urosepsis
    FM Wagenlehner et al. Curr Opin Urol 27 (2), 133-137. PMID 27846034. - Review
    Sepsis has still a high morbidity and mortality rate. Although definition and diagnosis of sepsis has been recently updated, its translation into urosepsis management req …
  • Urosepsis--from the View of the Urologist
    FM Wagenlehner et al. Int J Antimicrob Agents 38 Suppl, 51-7. PMID 21993485. - Review
    Urosepsis accounts for approximately 25% of all sepsis cases and may develop from a community-or nosocomial-acquired urinary tract infection (UTI). The underlying UTI is …
  • Pharmacokinetic Characteristics of Antimicrobials and Optimal Treatment of Urosepsis
    FM Wagenlehner et al. Clin Pharmacokinet 46 (4), 291-305. PMID 17375981. - Review
    Urosepsis accounts for approximately 25% of all sepsis cases and may develop from a community-acquired or nosocomial urinary tract infection (UTI). Nevertheless, the unde …
See all similar articles

Cited by 37 PubMed Central articles

See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources

Feedback